Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.60M | 23.67M | 16.20M | 12.35M | 15.03M |
| Total Other Revenue | 42.17M | 57.44M | 62.42M | 67.18M | 79.90M |
| Total Revenue | 79.76M | 81.10M | 78.63M | 79.53M | 94.93M |
| Cost of Revenue | 43.52M | 77.20M | 73.60M | 71.31M | 77.93M |
| Gross Profit | 36.24M | 3.91M | 5.03M | 8.21M | 16.99M |
| SG&A Expenses | 37.18M | 63.85M | 56.94M | 40.12M | 42.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 61.67M | -10.96M | -29.80M | 10.69M | 3.56M |
| Total Operating Expenses | 142.37M | 130.09M | 100.75M | 122.12M | 123.58M |
| Operating Income | -62.61M | -48.99M | -22.12M | -42.59M | -28.66M |
| Income Before Tax | 214.25M | -146.54M | -936.64M | 580.90M | -388.04M |
| Income Tax Expenses | 95.00K | 125.00K | 158.00K | 205.00K | 375.00K |
| Earnings from Continuing Operations | 214.15M | -146.66M | -936.80M | 580.69M | -388.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 214.15M | -146.66M | -936.80M | 580.69M | -388.41M |
| EBIT | -62.61M | -48.99M | -22.12M | -42.59M | -28.66M |
| EBITDA | -48.51M | -32.66M | -3.36M | -22.86M | -2.62M |
| EPS Basic | 0.59 | -0.46 | -0.84 | -0.17 | -1.00 |
| Normalized Basic EPS | 0.52 | -0.24 | -1.83 | 1.15 | -0.51 |
| EPS Diluted | 0.41 | -0.46 | -0.85 | -0.17 | -1.00 |
| Normalized Diluted EPS | 0.36 | -0.24 | -1.83 | 1.15 | -0.51 |
| Average Basic Shares Outstanding | 319.60M | 318.56M | 317.99M | 315.20M | 306.15M |
| Average Diluted Shares Outstanding | 464.57M | 318.56M | 317.99M | 315.20M | 306.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |